Cutler Group’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$3K Buy
+200
New +$4.61K ﹤0.01% 1748
2023
Q3
Sell
-8,080
Closed -$233K 4257
2023
Q2
$379K Buy
8,080
+180
+2% +$8.96K 0.05% 402
2023
Q1
$331K Sell
7,900
-300
-4% -$12.9K 0.03% 476
2022
Q4
$312K Hold
8,200
0.03% 600
2022
Q3
$321K Sell
8,200
-170
-2% -$6.57K 0.02% 727
2022
Q2
$270K Sell
8,370
-2,065
-20% -$69.2K 0.02% 833
2022
Q1
$345K Buy
10,435
+2,835
+37% +$107K 0.02% 850
2021
Q4
$323K Buy
7,600
+720
+10% +$30.1K 0.01% 988
2021
Q3
$304K Buy
6,880
+5,040
+274% +$231K 0.01% 1089
2021
Q2
$104K Sell
1,840
-2,086
-53% -$147K ﹤0.01% 1846
2021
Q1
$293K Buy
3,926
+3,002
+325% +$246K 0.01% 1029
2020
Q4
$79K Buy
+924
New +$68.1K ﹤0.01% 1685
2020
Q3
Sell
-1,100
Closed -$55.7K 5183
2020
Q2
$45K Buy
+1,100
New +$39.9K ﹤0.01% 1818
2020
Q1
Sell
-3,671
Closed -$213K 4552
2019
Q4
$265K Buy
+3,671
New +$452K 0.02% 688
2018
Q3
Sell
-1,500
Closed -$232K 4594
2018
Q2
$234K Buy
1,500
+407
+37% +$63.9K 0.02% 719
2018
Q1
$176K Buy
1,093
+3
+0.3% +$509 0.02% 888
2017
Q4
$179K Sell
1,090
-1,421
-57% -$138K 0.01% 1035
2017
Q3
$156K Sell
2,511
-29,031
-92% -$2.28M 0.01% 1339
2017
Q2
$2.51M Buy
31,542
+31,022
+5,966% +$2.24M 0.09% 179
2017
Q1
$36K Sell
520
-15,360
-97% -$900K ﹤0.01% 2724
2016
Q4
$810K Sell
15,880
-543
-3% -$25.6K 0.03% 482
2016
Q3
$756K Sell
16,423
-3,245
-16% -$132K 0.03% 435
2016
Q2
$592K Buy
19,668
+17,368
+755% +$579K 0.03% 504
2016
Q1
$73K Buy
2,300
+300
+15% +$10.6K ﹤0.01% 1923
2015
Q4
$116K Buy
+2,000
New +$99.1K 0.01% 1627

Other funds holding SAGE